Tributylphosphine → N-cyclopropyl-1-{4-[(ethylamino)carbonyl]phenyl}-5-{3-[4-(trifluoromethoxy)phenoxy]propyl}-1H-1,2,3-triazole-4-carboxamide
Reaction equation
[F:1][C:2]([F:12])([F:11])[O:3][C:4]1[CH:9]=[CH:8][C:7]([OH:10])=[CH:6][CH:5]=1.C(P(CCCC)CCCC)CCC.[CH:26]1([NH:29][C:30]([C:32]2[N:33]=[N:34][N:35]([C:41]3[CH:46]=[CH:45][C:44]([C:47]([NH:49][CH2:50][CH3:51])=[O:48])=[CH:43][CH:42]=3)[C:36]=2[CH2:37][CH2:38][CH2:39]O)=[O:31])[CH2:28][CH2:27]1.N(/C(N1CCCCC1)=O)=N\C(N1CCCCC1)=O>C1(C)C=CC=CC=1>[CH:26]1([NH:29][C:30]([C:32]2[N:33]=[N:34][N:35]([C:41]3[CH:42]=[CH:43][C:44]([C:47]([NH:49][CH2:50][CH3:51])=[O:48])=[CH:45][CH:46]=3)[C:36]=2[CH2:37][CH2:38][CH2:39][O:10][C:7]2[CH:6]=[CH:5][C:4]([O:3][C:2]([F:11])([F:12])[F:1])=[CH:9][CH:8]=2)=[O:31])[CH2:27][CH2:28]1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 4-(trifluoromethoxy)phenol (52 mg) in toluene (0.5 ml) was added a solution of tributylphosphine (51 mg) in toluene (0.5 ml) under stirring, a solution of N-cyclopropyl-1-{4-[(ethylamino)carbonyl]phenyl}-5-(3-hydroxypropyl)-1H-1,2,3-triazole-4-carboxamide (29 mg) in toluene (0.5 ml) and a solution of 1,1′-[(E)-diazene-1,2-diyldicarbonyl]dipiperidine in toluene (0.5 ml) were successively added, and the mixture was stirred at room temperature for 64 hr. The reaction mixture was filtered through a filter tube (Biospin column, Bio-Rad), and washed with 1 ml of ethyl acetate. The filtrates were combined, 1 ml of ethyl acetate and 1 ml of saturated aqueous sodium hydrogen carbonate solution were added, and the mixture was vigorously stirred at room temperature for 30 min. The organic layer was recovered using Presep™ Dehydration (Wako Pure Chemical Industries, Ltd.) and concentrated to dryness. The residue was dissolved in DMSO (0.7 ml) and purified by preparative HPLC (Gilson, Inc., high-throughput purification system, column: YMC CombiPrep ODS-A S-5 μm, 50×20 mm, solvent: solution A; 0.1% formic acid aqueous solution, solution B; 0.1% formic acid acetonitrile solution, gradient cycle: 0 min (solution A/solution B=95/5), 1.00 min (solution A/solution B=95/5), 5.20 min (solution A/solution B=5/95), 6.40 min (solution A/solution B=5/95), 6.50 min (solution A/solution B=95/5), 6.60 min (solution A/solution B=95/5), flow rate: 25 ml/min, detection method: UV 220 nm) to give the title compound (27 mg) (LC/MS purity 100%, ESI+:518 [M+H]+).
Workup
- stirringthe mixture was stirred at room temperature for 64 hr
- filtrationThe reaction mixture was filtered through a filter tube (Biospin column, Bio-Rad)
- washwashed with 1 ml of ethyl acetate
- addition1 ml of ethyl acetate and 1 ml of saturated aqueous sodium hydrogen carbonate solution were added
- stirringthe mixture was vigorously stirred at room temperature for 30 min
- customThe organic layer was recovered
- concentrationconcentrated to dryness
- dissolutionThe residue was dissolved in DMSO (0.7 ml)
- custompurified by preparative HPLC (Gilson, Inc., high-throughput purification system, column: YMC CombiPrep ODS-A S-5 μm, 50×20 mm, solvent: solution A; 0.1% formic acid aqueous solution, solution B; 0.1% formic acid acetonitrile solution, gradient cycle: 0 min (solution A/solution B=95/5), 1.00 min (solution A/solution B=95/5), 5.20 min (solution A/solution B=5/95), 6.40 min (solution A/solution B=5/95), 6.50 min (solution A/solution B=95/5), 6.60 min (solution A/solution B=95/5), flow rate: 25 ml/min, detection method: UV 220 nm)
Sources & evidence
- ORD record
- ord-a5b5fc9c3bdc4b5290db8172c28b6c7a
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07803822B2
Reaction notes
Loading…